Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases

Inhaled oligonucleotide is an emerging therapeutic modality for various common respiratory diseases, including obstructive airway diseases like asthma and chronic obstructive pulmonary disease (COPD) and restrictive airway diseases like idiopathic pulmonary fibrosis (IPF). The advantage of direct ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Wupeng, Dong, Jinrui, Peh, Hong Yong, Tan, Lay Hong, Lim, Kah Suan, Li, Li, Wong, Wai-Shiu Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155767/
https://www.ncbi.nlm.nih.gov/pubmed/28106744
http://dx.doi.org/10.3390/molecules22010139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155767/
https://www.ncbi.nlm.nih.gov/pubmed/28106744
http://dx.doi.org/10.3390/molecules22010139

Ejemplares similares